ABBV - AbbVie Inc.
Close
174.83
0.250 0.143%
Share volume: 105,851
Last Updated: Fri 10 Jan 2025 08:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.49%
PREVIOUS CLOSE
CHG
CHG%
$174.58
0.25
0.14%
Summary score
37%
Profitability
29%
Dept financing
33%
Liquidity
11%
Performance
52%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
13.03%
Return on assets
2.28%
Return on sales
27.95%
Return on invested capital
2.07%
Total debt ratio
91.02%
Debt ratio change over timeo
435.59%
Current Ratio
0.88%
Quick Ratio
0.76%
Cash Position Ratio
0.3%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
1.6%
Return on sales
24.8%
Return on invested capital
0%
Total debt ratio
94.49%
Debt ratio change over timeo
0%
Current Ratio
0.82%
Quick Ratio
0.71%
Cash Position Ratio
0.31%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
1.48%
Return on sales
22.73%
Return on invested capital
0%
Total debt ratio
94.62%
Debt ratio change over time
0%
Current Ratio
0.94%
Quick Ratio
0.83%
Cash Position Ratio
0.44%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
8875.73%
Return on assets
1022.16%
Return on sales
12706.05%
Return on invested capital
1240.12%
Total debt ratio
43558.54%
Debt ratio change over time
435.59%
Current Ratio
452.65%
Quick Ratio
385.68%
Cash Position Ratio
156.59%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABBV | AMGN | VRTX | REGN |
|---|---|---|---|---|
| Return on equity | 13.03% | 18.15% | 6.63% | 7.43% |
| Return on assets | 2.28% | 3.22% | 5.84% | 5.53% |
| Return on sales | 27.95% | 31.46% | 43.41% | 39.97% |
| Return on invested capital | 2.07% | 5.53% | 34.89% | 19.77% |
| Profitability | 45% | 61% | 84% | 71% |
| Total debt ratio | 91.02% | 90.77% | 24.67% | 26.45% |
| Debt ratio change over time | 435.59% | 17.23% | -0.06% | 1.17% |
| Dept financing | 50% | 26% | 7% | 7% |
| Current Ratio | 0.82% | 1.41% | 3.64% | 5.37% |
| Quick Ratio | 0.71% | 0.99% | 3.42% | 4.6% |
| Cash Position Ratio | 0.31% | 0.49% | 2.77% | 2.46% |
| Liquididy | 12% | 26% | 73% | 64% |
| Short-term ratios | ABBV | AMGN | VRTX | REGN |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 5.91% | 3.8% |
| Return on assets | 1.6% | 2.14% | 4.97% | 3.28% |
| Return on sales | 24.8% | 18.91% | 42.59% | 30.73% |
| Return on invested capital | 0% | 0% | 23.7% | 9.18% |
| Profitability | 23% | 22% | 100% | 60% |
| Total debt ratio | 94.49% | 93.35% | 24.56% | 21.77% |
| Debt ratio change over time | 0% | 0% | -0.62% | 1.41% |
| Dept financing | 25% | 25% | 6% | 31% |
| Current Ratio | 0.82% | 1.41% | 3.64% | 5.37% |
| Quick Ratio | 0.71% | 0.99% | 3.42% | 4.6% |
| Cash Position Ratio | 0.31% | 0.49% | 2.77% | 2.46% |
| Liquididy | 10% | 16% | 61% | 72% |